alexion share price & news
Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders. ALXN | Complete Alexion Pharmaceuticals Inc. stock news by MarketWatch. View recent trades and share price information for Alexion Pharmaceuticals Inc Contingent Value Rights … AstraZeneca’s surprise $39billion takeover bid for US biotech firm Alexion wiped 9.2% from its share price early today as investors struggled to identify benefits from the mammoth deal. Alexion is widely known for developing the drug Soliris, a treatment for paroxysmal nocturnal haemoglobinuria that received FDA approval in … The average Alexion Pharmaceuticals stock price for the last 52 weeks is 119.35 . View recent trades and share price information for Alexion Pharmaceuticals Inc Contingent Value Rights Alexion shareholders will be paid $60 USD per share in cash, as well as 2.1243 AstraZeneca American Depositary Shares (ADSs), amounting to a total consideration of $175 USD per share. AstraZeneca (AZN) and Alexion (ALXN) $39bn merger information including expected completion date, offer price and contact details are displayed in the acquisition details table below. At its peak, Alexion’s stock price exceeded $200 a share and commanded a high growth stock P/E ratio of close to 40, which up till then was justified and supported by its operating growth. Find the latest Alexion Pharmaceuticals, Inc. (ALXN) stock quote, history, news and other vital information to help you with your stock trading and investing. Alexion started the day with a market cap of around $26.5 billion with approximately 218.8 million shares outstanding and a short interest of about 1.9%. cumulative factor which encapsulates all splits since the date shown above. This move was aimed to diversify Alexion's hematology, neurology, and critical care commercial portfolio with Portola's Factor Xa inhibitor reversal agent. Real time Alexion Pharmaceuticals (ALXN) stock price quote, stock graph, news & analysis. $150.71. Over the last 12 months, Alexion Pharmaceuticals's shares have ranged in value from as little as $72.67 up to $162.6. One way of making that assessment is to exami... Why Alexion Pharmaceuticals Inc could appeal to contrarian val... 28th May '20 - Ben Hobson Amgen has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500. You can change your choices at any time by visiting Your Privacy Controls. Alexion Pharmaceuticals share price volatility. Alexion shareholders will be paid $60 USD per share in cash, as well as 2.1243 AstraZeneca American Depositary Shares (ADSs), amounting to a total consideration of $175 USD per share. The offer represents a 45% premium to Alexion's share price … Find real-time ALXN - Alexion Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Astra buys Alexion for a share price of $175 Reply 1 0 Report Juice Leskinen Dec 14, 2020 5:20AM ET Share Follow this post Unfollow this post Save Saved. Latest Stock Picks Investing Basics Premium Services … adjusted to account for any stock splits and/or dividends which may have AstraZeneca shares fell as much as 9% on Monday, as investors moved to price in the costs of a $39 billion deal for U.S. biotech company Alexion Pharmaceuticals that would be … Find real-time ALXN - Alexion Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Moreover, Alexion’s adjusted operating earnings have grown from $0.20 per share in 2008 to $10.53 by 2019, representing an outstanding 43.72% compound annualized growth … occurred for this security since the date shown above. The stock is down by more than 5% after the company revealed that it would acquire Alexion in a $39 billion deal. Nasdaq 100. Find market predictions, ALXN financials and market news. Alexion closed at $120.97 Wednesday, a 3.4% decrease from the same date three years ago. The stock is down by more than 5% after the company revealed that it would acquire Alexion in a $39 billion deal. This is in sharp contrast to its trading at approximately 11 times book value in 2013 and 2014, which is referenced … AstraZeneca is offering $60 in cash plus 2.1243 shares of stock for every Alexion share, representing a total package worth $175 per share based on AstraZeneca's closing stock price on … Each ADS represents one … 1:1. Earnings & Valuation This table compares Biogen and Alexion Pharmaceuticals' revenue, earnings per share (EPS) and valuation. $146.97. NASDAQ. © 2021 Alexion Pharmaceuticals, Inc. Alexion's investors will receive £45 cash and 2.1 Astra shares for each Alexion share – or £132 per share, a 45 per cent premium – handing them 15 per cent of the combined company. Data Provided by Refinitiv. Share Price vs. Fair Value Below Fair Value : ALXN ($153.48) is trading below our estimate of fair value ($300.83) Significantly Below Fair Value : ALXN is trading below fair value by more than 20%. But profits are on track to rise … What appears to be exercising some who follow AstraZeneca is the price it is paying. The Alexion Pharmaceuticals 52-week low stock price is 72.67, which is 51.6% below the current share price. AstraZeneca’s share price has now fallen by more than 20% from the 52-week high of 10,120p seen earlier this year. Price to Earnings Ratio vs. the Market The P/E ratio of Alexion Pharmaceuticals is 35.39, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 32.38. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alexion Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been 25.86%. Discover historical prices for ALXN stock on Yahoo Finance. The boards of directors of both companies have unanimously approved the acquisition. The latest closing stock price for Alexion Pharmaceuticals as of March 05, 2021 is 150.10.. Comparatively, Alexion Pharmaceuticals has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. (ALXN) Nasdaq Listed. Even after Ultomiris’ launch in late 2018, the company’s stock price has stayed pretty much flat. Historical daily share price chart and data for Alexion Pharmaceuticals since 1996 adjusted for splits. According to its third quarter financial update, Alexion’s revenue and GAAP earnings per share both popped 26%, to about $1.6 billion and $2.62, respectively, from the previous year. We and our partners will store and/or access information on your device through the use of cookies and similar technologies, to display personalised ads and content, for ad and content measurement, audience insights and product development. +0.61 (+0.41%) This represents a 45% premium to Alexion's closing share price … AstraZeneca has agreed to buy Alexion Pharmaceuticals in a mixed cash and shares deal worth $39bn. A popular way to gauge a stock's volatility is its "beta". 13,319.86. Share Price & News How has Alexion Pharmaceuticals's share price performed over time and what events caused price changes? At the current See Saved Items. By using our website, you agree to our use of cookies in accordance with our. Earnings for Alexion Pharmaceuticals are expected to grow by 5.30% in the coming year, from $11.14 to $11.73 per share. Alexion Pharmaceuticals Inc (ALXN) USD0.0001 Sell: $153.48 Buy: $153.52 Change: $0.87 (0.57%) NASDAQ : 0.04% AstraZeneca’s share price has now fallen by more than 20% from the 52-week high of 10,120p seen earlier this year. Alexion Pharmaceuticals share price volatility. Yahoo is part of Verizon Media. 3,943.34. Per the terms, Alexion’s shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) for each Alexion share. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide . The all-time high Alexion Pharmaceuticals stock closing price was 207.84 on July 23, 2015.; The Alexion Pharmaceuticals 52-week high stock price is 162.60, which is 8.3% above the current share price. 6,761.47. Shares in Alexion Pharmaceuticals Inc (NSQ:ALXN) are currently trading at 109.82 but a key question for investors is how the economic uncertainty caused by Coronavirus will affect the price. Alexion Pharmaceuticals Stock Forecast, AXP stock price prediction. See Saved Items. Intraday Alexion Pharmac Share Chart. Elliott did not immediately respond to a request for comment. Discover historical prices for ALXN stock on Yahoo Finance. Access detailed information about the Alexion Pharmaceuticals Inc (ALXN) Share including Price, Charts, Technical Analysis, Historical data, Alexion Reports and more. The Split Adjustment Factor is a This website is intended only for residents of the United States. Over the last 12 months, Alexion Pharmaceuticals's shares have ranged in value from as little as $72.67 up to $162.6. DJIA. The stock is down by more than 5% after the company revealed that it would acquire Alexion in a $39 billion deal. [1] The agreed price represents a 45% premium over Alexion’s share price, and will be AstraZeneca’s largest acquisition to date, assuming it receives regulatory and shareholder’s approval. S&P 500. In May 2020, Alexion announced an agreement to acquire Portola Pharmaceuticals for $18 per share using cash. Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). Elliott first invested in Alexion in 2017 when the share price was only slightly lower than Friday's close of $120.98. Minimum 15 minutes delayed. A popular way to gauge a stock's volatility is its "beta". Astra buys Alexion for a share price of $175 Reply 1 0 Report Juice Leskinen Dec 14, 2020 5:20AM ET Share Follow this post Unfollow this post Save Saved. ALXN.US volatility (beta: 1.34) Avg. ALXN.US volatility (beta: 1.34) Avg. Long-Term Price Volatility Vs. Market How volatile is Alexion Pharmaceuticals's share price compared to the market and industry in the last 5 years? Based on AstraZeneca's reference average ADR price of $54.14, this implies total consideration to Alexion shareholders of $39bn or $175 per share. 32,778.64. Data is currently not available. The latest Alexion Pharmaceuticals Inc Contingent Value Rights share price. Alexion Pharmaceuticals, Inc. Common Stock. View live ALEXION PHARMACEUTICAL INC chart to track its stock's price action. Alexion Pharmaceuticals Inc A Boston pharmaceutical company, Alexion Pharmaceuticals Inc. focuses primarily on immune system research and rare blood disorders. volatility (beta: 1.00) Low High. AstraZeneca share price is the worst-performer in the FTSE 100 today. Palatin (PTN) Jumps: Stock Rises 8.7% Palatin (PTN) saw a big move last The offer values Alexion at $175 a share, a 45% premium to the closing price on Friday. Over the last year, Alexion Pharmac share price has been traded in a range of 81.53464, hitting a high of 161.65318, and a low of 80.11854. What appears to be exercising some who follow AstraZeneca is the price it is paying. AstraZeneca share price is the worst-performer in the FTSE 100 today. Alexion Pharmaceuticals: Price-To-Book Value Suggest Undervaluation Alexion ended 2019 with the stock price trading at 2.12 times book value. Alexion closed at $120.97 Wednesday, a 3.4% decrease from the same date three years ago. Elliott did not immediately respond to a request for comment. Alexion Pharmaceuticals Inc,ALXN,ISIN: US0153511094 - view the latest price,charts and performance information at AJ Bell Youinvest Skip to main content Alexion Pharmaceuticals Inc (NASDAQ:ALXN) - Share price Other top laggards in the FTSE NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above.